TNG Pharmaceuticals' Angel Round

TNG Pharmaceuticals raised a round of funding on January 01, 2013. Investors include Angel Investor Management Group.

TNG Pharmaceuticals is furthering the development of a patented vaccine, FlyVax. FlyVax is a veterinary vaccine that is expected to inhibit the horn fly's ability to effectively feed on cattle. FlyVax…

Articles about TNG Pharmaceuticals' Angel Round: